UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacokinetics, Safety, and Efficacy of Trastuzumab Administered Every Three Weeks in Combination With Paclitaxel

Journal of clinical oncology, 2003-11, Vol.21 (21), p.3965-3971

2003

Volltextzugriff (PDF)

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

The New England journal of medicine, 2001-03, Vol.344 (11), p.783-792

2001

Volltextzugriff (PDF)

Essential roles of IGFBP-3 and IGFBP-rP1 in breast cancer

European journal of cancer (1990), 2005-07, Vol.41 (11), p.1515-1527

2005

Volltextzugriff (PDF)

Comparative Cytotoxicity of C-1311 in Colon Cancer In Vitro and In Vivo Using the Hollow Fiber Assay

Journal of chemotherapy (Florence), 2007-10, Vol.19 (5), p.546-553

2007

Volltextzugriff (PDF)

Synthesis and structure-activity relationships of 2-pyrazinylcarboxamidobenzoates and β-ionylideneacetamidobenzoates with retinoidal activity

Journal of medicinal chemistry, 1998-07, Vol.41 (16), p.3062-3077

1998

Volltextzugriff (PDF)

Dose Scheduling – Herceptin

Oncology, 2001-01, Vol.61 (Suppl 2), p.31-36

Leyland-Jones, Brian

2001

Volltextzugriff (PDF)

Pharmacologic insights into the future of trastuzumab

Annals of oncology, 2001, Vol.12, p.43-47

2001

Volltextzugriff (PDF)

Cephalotaxine Esters: Antileukemic Advance or Therapeutic Failure?

JNCI : Journal of the National Cancer Institute, 1988-09, Vol.80 (14), p.1095-1103

1988

Volltextzugriff (PDF)

Antineoplastic drug sensitivity of human MCF-7 breast cancer cells stably transfected with a human α class glutathione S-transferase gene

Cancer research (Chicago, Ill.), 1991-01, Vol.51 (2), p.587-594

1991

Volltextzugriff (PDF)

Erythropoietin as a critical component of breast cancer therapy: survival, synergistic, and cognitive applications

Seminars in oncology, 2003-10, Vol.30 (5), p.174-184

LEYLANDJONES, B

2003

Volltextzugriff (PDF)

Sensitive and specific determination of the new anthracycline analog 4'-epidoxorubicin and its metabolites by high pressure liquid chromatography

Drug metabolism and disposition, 1984-01, Vol.12 (1), p.9

1984

Volltextzugriff (PDF)

Role of Herceptin® in Primary Breast Cancer: Views from North America and Europe

Oncology, 2001-01, Vol.61 (Suppl 2), p.83-91

2001

Volltextzugriff (PDF)

Design and mechanism of action of a novel cytotoxic 1,2,3-triazene-containing heterocycle, 3,5-dimethyl-pyrido-1,2,3,5-tetrazepin-4-one (PYRZ), in the human epithelial ovarian cancer cell line NIH:OVCAR-3 in vitro

British journal of cancer, 1997-01, Vol.76 (4), p.467-473

1997

Volltextzugriff (PDF)

Biotransformation and elimination of [2-14C]-1-(2-deoxy-2'-fluoro-beta-D -arabinofuranosyl)-5-iodocytosine in immunosuppressed patients with herpesvirus infections

Antimicrobial Agents and Chemotherapy, 1985-05, Vol.27 (5), p.733-738

1985

Volltextzugriff (PDF)

The Role of Methotrexate in Osteosarcoma

JNCI : Journal of the National Cancer Institute, 1988-07, Vol.80 (9), p.626-655

1988

Volltextzugriff (PDF)

4-Ipomeanol: A Novel Investigational New Drug for Lung Cancer

JNCI : Journal of the National Cancer Institute, 1989-08, Vol.81 (15), p.1133-1143

1989

Volltextzugriff (PDF)

Stability of 5-acetamido-6-formylamino-3-methyluracil in buffers and urine

Journal of pharmaceutical and biomedical analysis, 2002-05, Vol.28 (3), p.693-700

2002

Volltextzugriff (PDF)

Pentostatin in Hairy Cell Leukemia: Treatment by the Special Exception Mechanism

JNCI : Journal of the National Cancer Institute, 1989-03, Vol.81 (6), p.448-453

1989

Volltextzugriff (PDF)

Genomic Imbalances Associated with Acquired Resistance to Platinum Analogues

The American journal of pathology, 1999-07, Vol.155 (1), p.77-84

1999

Volltextzugriff (PDF)

Reversal of multidrug resistance to cancer chemotherapy

Cancer, 1993-12, Vol.72 (S11), p.3484-3488

1993

Volltextzugriff (PDF)

Etoposide (VP-16-213). Current status of an active anticancer drug

The New England journal of medicine, 1985-03, Vol.312 (11), p.692-700

1985

Volltextzugriff (PDF)

Central nervous system toxicity of fludarabine phosphate

Cancer treatment reports, 1986-10, Vol.70 (10), p.1225

1986

Volltextzugriff (PDF)

Tamoxifen metabolic patterns within a glioma patient population treated with high‐dose tamoxifen

British journal of clinical pharmacology, 1997-02, Vol.43 (2), p.189-193

1997

Volltextzugriff (PDF)

Cytokinetics of a novel 1,2,3-triazene-containing heterocycle, 8-nitro-3-methyl-benzo-1,2,3,5-tetrazepin-4(3 H)-one (NIME), in the human epithelial ovarian cancer cell line OVCAR-3

Biochemical pharmacology, 1999-04, Vol.57 (7), p.753-762

1999

Volltextzugriff (PDF)

Azacitidine: 10 years later

Cancer treatment reports, 1987-07, Vol.71 (7-8), p.737

1987

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

ThemaPharmacology. Drug Treatments

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)

Publikationsform

Artikel
(66)

Sprache

Englisch
(66)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(66)
Medical Sciences
(66)
Humans
(60)
Life Sciences & Biomedicine
(54)
Science & Technology
(54)
Antineoplastic Agents
(48)
Oncology
(43)
Drug Evaluation
(26)
Female
(26)
Animals
(22)
Chemotherapy
(22)
General Aspects
(22)
Clinical Trials As Topic
(18)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(16)
Antineoplastic Agents - Therapeutic Use
(15)
Adult
(14)
Male
(13)
Neoplasms - Drug Therapy
(13)
Pharmacology & Pharmacy
(13)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics, Safety, and Efficacy of Trastuzumab Administered Every Three Weeks in Combination With Paclitaxel

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

Essential roles of IGFBP-3 and IGFBP-rP1 in breast cancer

Comparative Cytotoxicity of C-1311 in Colon Cancer In Vitro and In Vivo Using the Hollow Fiber Assay

Synthesis and structure-activity relationships of 2-pyrazinylcarboxamidobenzoates and β-ionylideneacetamidobenzoates with retinoidal activity

Dose Scheduling – Herceptin

Pharmacologic insights into the future of trastuzumab

Cephalotaxine Esters: Antileukemic Advance or Therapeutic Failure?

Antineoplastic drug sensitivity of human MCF-7 breast cancer cells stably transfected with a human α class glutathione S-transferase gene

Erythropoietin as a critical component of breast cancer therapy: survival, synergistic, and cognitive applications

Sensitive and specific determination of the new anthracycline analog 4'-epidoxorubicin and its metabolites by high pressure liquid chromatography

Role of Herceptin® in Primary Breast Cancer: Views from North America and Europe

Design and mechanism of action of a novel cytotoxic 1,2,3-triazene-containing heterocycle, 3,5-dimethyl-pyrido-1,2,3,5-tetrazepin-4-one (PYRZ), in the human epithelial ovarian cancer cell line NIH:OVCAR-3 in vitro

Biotransformation and elimination of [2-14C]-1-(2-deoxy-2'-fluoro-beta-D -arabinofuranosyl)-5-iodocytosine in immunosuppressed patients with herpesvirus infections

The Role of Methotrexate in Osteosarcoma

4-Ipomeanol: A Novel Investigational New Drug for Lung Cancer

Stability of 5-acetamido-6-formylamino-3-methyluracil in buffers and urine

Pentostatin in Hairy Cell Leukemia: Treatment by the Special Exception Mechanism

Genomic Imbalances Associated with Acquired Resistance to Platinum Analogues

Reversal of multidrug resistance to cancer chemotherapy

Etoposide (VP-16-213). Current status of an active anticancer drug

Central nervous system toxicity of fludarabine phosphate

Tamoxifen metabolic patterns within a glioma patient population treated with high‐dose tamoxifen

Cytokinetics of a novel 1,2,3-triazene-containing heterocycle, 8-nitro-3-methyl-benzo-1,2,3,5-tetrazepin-4(3 H)-one (NIME), in the human epithelial ovarian cancer cell line OVCAR-3

Azacitidine: 10 years later

Aktive Filter

Suchergebnisse filtern